| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Mbx Biosciences IncMBX | +171.68% | $12.43 | $33.77 | 2025-07-16 - 2026-04-17 | Buy |
Palvella Therapeutics IncPVLA | +129.25% | $56.71 | $130.01 | 2025-09-09 - 2026-04-17 | Buy |
Ligand Pharmaceuticals IncLGND | +121.88% | $104.48 | $231.82 | 2025-05-09 - 2026-04-17 | Buy |
Mbx Biosciences IncMBX | +78.11% | $18.96 | $33.77 | 2025-09-23 - 2026-04-17 | Buy |
Ligand Pharmaceuticals IncLGND | +71.43% | $135.23 | $231.82 | 2025-07-30 - 2026-04-17 | Buy |
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Ligand Pharmaceuticals IncLGND | 8 | Buy | $277.00 | +19.49% | Maintains | 2 months ago |
Bridgebio Pharma IncBBIO | 2 | Buy | $81.00 | +5.54% | Maintains | 2 months ago |
Legend Biotech CorpLEGN | 1 | Buy | $75.00 | +254.27% | Initiates Coverage On | 3 months ago |
Design Therapeutics IncDSGN | 1 | Buy | $18.00 | +37.20% | Initiates Coverage On | 3 months ago |
Theravance Biopharma IncTBPH | 1 | Buy | $27.00 | +56.70% | Initiates Coverage On | 5 months ago |
Mbx Biosciences IncMBX | 2 | Buy | $80.00 | +136.90% | Maintains | 7 months ago |
Palvella Therapeutics IncPVLA | 1 | Buy | $85.00 | -34.62% | Initiates Coverage On | 7 months ago |
Innoviva IncINVA | 1 | Buy | $35.00 | +44.39% | Initiates Coverage On | 8 months ago |